# Rentschler Biopharma SE – FDA Inspection, Dec 6, 2016

Source: https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/fd3c2655-b57f-4166-9399-c3a17930da99
Source feed: FDA_Inspections

> FDA inspection 999800 of Rentschler Biopharma SE, December 06, 2016. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 999800
- Company Name: Rentschler Biopharma SE
- Inspection Date: 2016-12-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1246782 - 2023-05-05](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/0d912736-9230-4aef-96a6-874067c47f8c)
- [FDA Inspection 1202157 - 2023-03-07](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/300ac9e9-db9e-4c2e-a99e-94a03668b9ed)
- FDA Inspection 1160831 - 2021-02-26
- FDA Inspection 1102650 - 2019-08-09
- FDA Inspection 1046488 - 2018-03-08

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/djamila-harouaka/106cef03-a214-4184-963a-6580d3bd7fd9)
- [FDA Associated Person](https://www.keypedia.com/people/truong-x-nguyen/8f3aed17-0507-4272-a3b8-9188d761faed)

Company: https://www.keypedia.com/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c